Donald J Trump (R) Sells DocuSign (DOCU) Stock
Donald J Trump recently sold DocuSign shares, valued between $15,001 and $50,000.
Reviewed by automated data checks against the source filing. How we make and check alerts
Donald J Trump (R) sold between $15,001 and $50,000 of DocuSign, Inc. ($DOCU) stock on May 22, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed July 1, 2026.
Since the trade, $DOCU is up 6.0% after 1 week, down 13.8% after 1 month and up 50.7% to date (from the $49.53 close on May 22, 2026).
Financial Disclosure Report
United States Congress • Office of Public Records • Washington, DC
Filer Information
- Name:
- Donald J Trump (R)
- Status:
- Member
- Party:
- republican
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jul 1, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| DocuSign, Inc. ($DOCU) | Sell | May 22, 2026 | $15,001 - $50,000 |
Summary of the filed report, not the original document.
Key Points
- Donald J Trump sold DocuSign shares on May 22, valued between $15,001 and $50,000.
- DocuSign has a market cap of $8.48 billion, with a P/E ratio of 28.8 and a 52-week range from $40.16 to $86.65.
- BlackRock reduced its DocuSign holdings by 1,971,665 shares, while Vanguard Portfolio Management opened a new position.
Get $DOCU trade alerts by text
We text you when insiders, Congress or big funds trade $DOCU. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated DocuSign, Inc. alert may contain errors. Disclosures
On May 22, 2026, Donald J Trump sold shares of DocuSign, Inc. (NASDAQ: DOCU) valued between $15,001 and $50,000. This transaction was reported on July 1, 2026, and is part of the periodic disclosures required under the STOCK Act.
Donald J Trump vs. the S&P 500
Hypothetical returns from Donald J Trump's disclosed trades, not real profit or advice. How we model this.
DocuSign, Inc. Stock Down 35.9%
Shares of NASDAQ:DOCU traded near $44.3 on Wednesday. DocuSign has a market capitalization of approximately $8.48 billion. The company has a P/E ratio of 28.8 and a forward P/E of 8.7, reflecting its earnings potential. Its beta of 0.883 suggests lower volatility compared to the broader market. Over the past year, the stock has ranged from a low of $40.16 to a high of $86.65. The 50-day moving average is $47.05, while the 200-day moving average is $57.78.
Recent Earnings
DocuSign reported revenue of about $3.29 billion, showing a growth rate of 8.7%. The company achieved a net margin of 9.6% and a return on equity of 16.4%. Earnings per share were $1.54. The next earnings report is scheduled for September 3, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
3 target cuts vs 2 raises.
-
EPS & revenue
EPS beat estimates by 7.8%. Revenue missed estimates by 1.3%.
-
Profit surprise
EBITDA missed by 58 percent. Operating income missed by 55 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target raises, 3 target cuts.
-
Earnings quality
Operating margin up 5.5 points. Positive free cash flow.
Earnings Call Summary
The company reported 801 million dollars in revenue and 818 million dollars in billings, both growing 9 percent and 13 percent year over year respectively. Management highlighted strong eSignature fundamentals, improved dollar net retention to 102 percent, and accelerating IAM adoption. They raised full-year guidance and returned 200 million dollars to shareholders through buybacks, while maintaining 30 percent non-GAAP operating margins.
Guidance DocuSign expects third quarter revenue of about 806 million dollars, up 7 percent year over year. For the full year, they now forecast 3 point 195 billion dollars in revenue, up 38 million dollars from prior guidance, driven by strong eSignature and early IAM momentum.
Negative report. Results or guidance disappointed and expectations are likely to move lower.
Other Institutional Activity in DocuSign
BlackRock, Inc. trimmed its holdings in DocuSign by 1,971,665 shares, leaving it with 21,564,137 shares valued at roughly $1.02 billion, marking an 8.4% decrease. Vanguard Portfolio Management LLC opened a new position with 11,287,298 shares worth about $535.1 million. Similarly, Vanguard Capital Management LLC also initiated a stake, holding 8,955,214 shares valued at approximately $424.6 million. Capital World Investors increased its holdings by 1,224,001 shares to 7,039,805 shares, a 21.0% increase, valued at $333.8 million. Meanwhile, State Street Corp reduced its stake by 1,367,069 shares, now holding 6,826,736 shares worth around $323.7 million, a 16.7% decrease.
Insider Buying and Selling at DocuSign, Inc.
Several insiders at DocuSign have been active in the market. On June 22, 2026, Robert Chatwani, President and General Manager of Growth, sold 15,902 shares at an average price of $43.01 under a planned sale. On June 15, 2026, Paula Hansen, Chief Revenue Officer, sold 16,123 shares. Additionally, Allan Thygesen, President and CEO, executed multiple sales on the same day, totaling over 97,000 shares.
Analysts Set New Price Targets
On June 5, 2026, Citigroup, Jefferies, Wells Fargo, and Wedbush all maintained their 'hold' ratings on DocuSign, with price targets of $54, $50, $55, and $58 respectively. BTIG maintained a 'buy' rating with a target of $60. The consensus recommendation for DocuSign is 'hold', with an average target price of $59.33 based on 18 analyst opinions.
About DocuSign, Inc.
DocuSign, Inc., headquartered in San Francisco, California, is a leading provider of electronic signature and agreement management solutions. With a focus on streamlining the agreement process, DocuSign offers a comprehensive suite of products including e-signature, contract lifecycle management, and document generation. The company's solutions are utilized across various industries, enhancing efficiency and compliance in agreement processes. DocuSign was founded in 2003 and is led by CEO Allan C. Thygesen.
Bottom Line
Donald J Trump's recent sale of DocuSign shares adds to the ongoing institutional activity around the stock. Investors closely monitor these moves for insight into market sentiment. DocuSign's financial performance and analyst ratings suggest a mixed outlook, with the stock trading below its recent highs. As always, it's important to remember that these disclosures reflect past transactions and may not indicate current positions.
Source: Donald J Trump's STOCK Act disclosure on $DOCU (May 22, 2026). Written by software, not financial advice. How we make alerts